111 related articles for article (PubMed ID: 16499580)
1. Monitoring tolerance induction.
Iacomini J
Pediatr Transplant; 2006 Feb; 10(1):5-6. PubMed ID: 16499580
[No Abstract] [Full Text] [Related]
2. Comments on 'Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism' by Mache et al. (Pediatr Transplant 2006;10:128-131).
Urban C; Lackner H; Benesch M; Sovinz P; Dornbusch HJ; Moser A; Schwinger W
Pediatr Transplant; 2006 Sep; 10(6):749-50; author reply 751-2. PubMed ID: 16911503
[No Abstract] [Full Text] [Related]
3. Should skin grafts be used to test for tolerance?
Deeg HJ
Pediatr Transplant; 2006 Sep; 10(6):755. PubMed ID: 16911506
[No Abstract] [Full Text] [Related]
4. Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism.
Mache CJ; Schwinger W; Spendel S; Zach O; Regauer S; Ring E
Pediatr Transplant; 2006 Feb; 10(1):128-31. PubMed ID: 16499603
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of idiopathic aplastic anemia in children].
Huang SL; Huang YL
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Feb; 11(2):81-7. PubMed ID: 19222939
[No Abstract] [Full Text] [Related]
6. Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Sorror ML; Leisenring W; Deeg HJ; Martin PJ; Storb R
Biol Blood Marrow Transplant; 2005 Jul; 11(7):567-8. PubMed ID: 15983557
[No Abstract] [Full Text] [Related]
7. [Allogeneic hematopoietic stem cell transplantation for 16 patients with aplastic anemia].
Zhai WH; Wang M; Zhou Z; Zhai WJ; Zhang RL; Wang H; Song AX; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):78-82. PubMed ID: 17650665
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen.
Resnick IB; Aker M; Shapira MY; Tsirigotis PD; Bitan M; Abdul-Hai A; Samuel S; Ackerstein A; Gesundheit B; Zilberman I; Miron S; Yoffe L; Lvovich A; Slavin S; Or R
Br J Haematol; 2006 Jun; 133(6):649-54. PubMed ID: 16704442
[TBL] [Abstract][Full Text] [Related]
9. Elevated blood drug levels obtained from indwelling silicon catheters during oral cyclosporine A administration.
Claviez A; Glass B; Dreger P; Suttorp M
Bone Marrow Transplant; 2002 Mar; 29(6):535-6. PubMed ID: 11960277
[TBL] [Abstract][Full Text] [Related]
10. [Possibilities and limits of kidney transplantation].
Brosig W
Z Urol Nephrol; 1969 Dec; 62(12):947-54. PubMed ID: 4909340
[No Abstract] [Full Text] [Related]
11. Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.
Koh LP; Koh MB; Ng HY; Hwang WY; Goh YT; Linn YC; Ng HJ; Chuah CT; Tan KW; Loh YS; Tan DC; Tan PH; Tan PH
Biol Blood Marrow Transplant; 2006 Aug; 12(8):887-90. PubMed ID: 16864060
[No Abstract] [Full Text] [Related]
12. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.
Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M
Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010
[TBL] [Abstract][Full Text] [Related]
13. [Treatment outcome of hematopoietic stem cell transplantation for aplastic anemia].
Okamoto S
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1309-15. PubMed ID: 16097585
[No Abstract] [Full Text] [Related]
14. Sirolimus-related toxicity in stem cell transplantation.
Busca A; Locatelli F; Moscato D; Falda M
Biol Blood Marrow Transplant; 2005 Aug; 11(8):647-9. PubMed ID: 16041315
[No Abstract] [Full Text] [Related]
15. Stem Cell Transplantation in Aplastic Anaemia.
Nair V; Apte S
J Assoc Physicians India; 2015 Mar; 63(3 Suppl):21-5. PubMed ID: 26529863
[No Abstract] [Full Text] [Related]
16. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
17. Renal transplantation after myeloablative and non-myeloablative hematopoietic cell transplantation from the same donor.
Tanaka T; Ishida H; Shirakawa H; Amano H; Nishida H; Tanabe K
Int J Urol; 2007 Nov; 14(11):1044-5. PubMed ID: 17956534
[TBL] [Abstract][Full Text] [Related]
18. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
[TBL] [Abstract][Full Text] [Related]
19. Individual physician practice variation in hematopoietic cell transplantation.
Lee SJ; Joffe S; Artz AS; Champlin RE; Davies SM; Jagasia M; Kernan NA; Loberiza FR; Soiffer RJ; Eapen M
J Clin Oncol; 2008 May; 26(13):2162-70. PubMed ID: 18378566
[TBL] [Abstract][Full Text] [Related]
20. Periodontal treatment considerations for cell transplant and organ transplant patients.
Vasanthan A; Dallal N
Periodontol 2000; 2007; 44():82-102. PubMed ID: 17474927
[No Abstract] [Full Text] [Related]
[Next] [New Search]
